Association between healthcare funding source and overall survival in patients with cervical cancer: A study from a large public database in São Paulo, Brazil
BACKGROUND: Previous studies have shown disparities in cancer outcomes according to the healthcare funding source. Here, we aimed to analyze the overall survival (OS) of patients with cervical cancer treated in the public and private healthcare systems in São Paulo, Brazil. METHODS: This retrospective cohort study analyzed patients with cervical cancer enrolled in the Registro Hospitalar de Câncer da Fundação Oncocentro de São Paulo (RHC-FOSP) database, with diagnosis between January 2012 and December 2019. The primary objective was to compare OS of patients treated with public versus private healthcare funding. The type of funding source was determined by the healthcare service involved in the initial evaluation and treatment. For descriptive purposes, subgroup analyses considering the age group, educational level, and TNM stage at diagnosis were performed. RESULTS: Of the 21,993 individuals with cervical cancer recorded in the RHC-FOSP database, 11,662 were included in the analysis (10,985 [94.2%] with public healthcare funding; 677 [5.8%] with private funding). Patients in the private system were younger and had higher educational levels than those in the public system. At 5-year follow-up, the median OS was not reached. Private funding was associated with significantly higher OS compared with public funding, with 5-year crude OS rates of 67.3% (95% CI, 63.1-71.8) and 50.4% (95% CI, 49.5-51.4), respectively. After adjusting for age and TNM stage, public funding was still associated with a worse prognosis for patients with more than 8 years of education versus private funding (adjusted HR of 1.36; 95% CI, 1.08-1.72, P = 0.009). CONCLUSION: Public healthcare funding is significantly associated with a worse OS in patients with cervical cancer in São Paulo, Brazil. These findings highlight the need for policy interventions to improve timely access to optimal cancer care, particularly in the public sector.
Authors
- Patrícia Klarmann Ziegelmann (ORCID: https://orcid.org/0000-0001-8012-3761)
- Fernando Cotait Maluf (ORCID: https://orcid.org/0000-0002-4288-9018)
- Cintia Kurokawa La Scala de Oliveira (ORCID: https://orcid.org/0000-0001-7385-5729)
- Ligia Casão Arteaga Maluf
Institutions
- Universidade Federal do Rio Grande do Sul (BR)
- Hospital Israelita Albert Einstein (BR)
- Beneficência Portuguesa de São Paulo (BR)
Publication Details
- Journal
- Cancer Epidemiology
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1016/j.canep.2026.103278
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Roche Canada